Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What "Big News" Awaits Us Tomorrow?

Perhaps the "non-executives" will retain Baroni for a strategic assessment of the MMP, as opposed to say PDSG

As he has already been retained to assess PDSG your suggestion is redundant.

Just what makes you think that if he were subsequently retained for the MMP Portfolio, he would have better insight into the percentage infringing chips and then the percentage of an infringers overall product range which infringed?

It is only worth what individual infringers are going to pay, no more, no less.

.

.

Be well

Share
New Message
Please login to post a reply